![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
X
20
Sinbiotik S.a. De C.v. Tlalnepantla De Baz Mx, based in Mexico, is a pharmaceutical company.
One of their significant offerings is Pentoxifylline, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2019-273 - Rev 01
This Chemical Type CEP, issued on February 15, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 851 associated with this CEP further emphasizes